SNHG16 and metabolic dysfunction-associated steatotic liver disease: Overall, this study investigated the gene expression profiles and immune cell infiltration landscapes in both MASLD and control groups, highlighting the potential role of SNHG16, CASP6, and DNM1L in PANoptosis during the immune/inflammatory response in MASLD.